These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 23955088)
21. Activation of the FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by alpha1-integrins during colon cancer cell invasion. Van Slambrouck S; Grijelmo C; De Wever O; Bruyneel E; Emami S; Gespach C; Steelant WF Int J Oncol; 2007 Dec; 31(6):1501-8. PubMed ID: 17982677 [TBL] [Abstract][Full Text] [Related]
22. Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation. Li H; Huang F; Fan L; Jiang Y; Wang X; Li J; Wang Q; Pan H; Sun J; Cao X; Wang X Oncogene; 2014 Sep; 33(37):4589-98. PubMed ID: 24276246 [TBL] [Abstract][Full Text] [Related]
23. Neutrophil granulocytes promote the migratory activity of MDA-MB-468 human breast carcinoma cells via ICAM-1. Strell C; Lang K; Niggemann B; Zaenker KS; Entschladen F Exp Cell Res; 2010 Jan; 316(1):138-48. PubMed ID: 19747913 [TBL] [Abstract][Full Text] [Related]
24. Signal transduction by focal adhesion kinase in cancer. Zhao J; Guan JL Cancer Metastasis Rev; 2009 Jun; 28(1-2):35-49. PubMed ID: 19169797 [TBL] [Abstract][Full Text] [Related]
25. Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Wang L; Ling Y; Chen Y; Li CL; Feng F; You QD; Lu N; Guo QL Cancer Lett; 2010 Nov; 297(1):42-8. PubMed ID: 20580866 [TBL] [Abstract][Full Text] [Related]
26. Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2 -9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways. Lu KW; Chen JC; Lai TY; Yang JS; Weng SW; Ma YS; Lu PJ; Weng JR; Chueh FS; Wood WG; Chung JG Hum Exp Toxicol; 2011 May; 30(5):406-15. PubMed ID: 20511288 [TBL] [Abstract][Full Text] [Related]
27. CADPE inhibits PMA-stimulated gastric carcinoma cell invasion and matrix metalloproteinase-9 expression by FAK/MEK/ERK-mediated AP-1 activation. Han H; Du B; Pan X; Liu J; Zhao Q; Lian X; Qian M; Liu M Mol Cancer Res; 2010 Nov; 8(11):1477-88. PubMed ID: 21047770 [TBL] [Abstract][Full Text] [Related]
28. A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin β1/FAK/PI3K/AKT/β-catenin signaling. Qin J; Tang J; Jiao L; Ji J; Chen WD; Feng GK; Gao YH; Zhu XF; Deng R Life Sci; 2013 Nov; 93(18-19):655-63. PubMed ID: 24044886 [TBL] [Abstract][Full Text] [Related]
29. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Fernandis AZ; Prasad A; Band H; Klösel R; Ganju RK Oncogene; 2004 Jan; 23(1):157-67. PubMed ID: 14712221 [TBL] [Abstract][Full Text] [Related]
30. Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells. Burdick AD; Davis JW; Liu KJ; Hudson LG; Shi H; Monske ML; Burchiel SW Cancer Res; 2003 Nov; 63(22):7825-33. PubMed ID: 14633709 [TBL] [Abstract][Full Text] [Related]
31. Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells. Hui AY; Meens JA; Schick C; Organ SL; Qiao H; Tremblay EA; Schaeffer E; Uniyal S; Chan BM; Elliott BE J Cell Biochem; 2009 Aug; 107(6):1168-81. PubMed ID: 19533669 [TBL] [Abstract][Full Text] [Related]
32. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin. Hwangbo C; Kim J; Lee JJ; Lee JH Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126 [TBL] [Abstract][Full Text] [Related]
33. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways. Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742 [TBL] [Abstract][Full Text] [Related]
34. Glabridin inhibits migration, invasion, and angiogenesis of human non-small cell lung cancer A549 cells by inhibiting the FAK/rho signaling pathway. Tsai YM; Yang CJ; Hsu YL; Wu LY; Tsai YC; Hung JY; Lien CT; Huang MS; Kuo PL Integr Cancer Ther; 2011 Dec; 10(4):341-9. PubMed ID: 21059620 [TBL] [Abstract][Full Text] [Related]
35. Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. Cortes-Reynosa P; Robledo T; Macias-Silva M; Wu SV; Salazar EP Matrix Biol; 2008 Apr; 27(3):220-31. PubMed ID: 18061419 [TBL] [Abstract][Full Text] [Related]
36. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546 [TBL] [Abstract][Full Text] [Related]
37. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth. Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110 [TBL] [Abstract][Full Text] [Related]
38. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK. Lee LF; Louie MC; Desai SJ; Yang J; Chen HW; Evans CP; Kung HJ Oncogene; 2004 Mar; 23(12):2197-205. PubMed ID: 14767470 [TBL] [Abstract][Full Text] [Related]
39. Arachidonic acid promotes migration and invasion through a PI3K/Akt-dependent pathway in MDA-MB-231 breast cancer cells. Villegas-Comonfort S; Castillo-Sanchez R; Serna-Marquez N; Cortes-Reynosa P; Salazar EP Prostaglandins Leukot Essent Fatty Acids; 2014 May; 90(5):169-77. PubMed ID: 24565443 [TBL] [Abstract][Full Text] [Related]
40. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: II. Effects on integrins and focal adhesions. Tantivejkul K; Vucenik I; Shamsuddin AM Anticancer Res; 2003; 23(5A):3681-9. PubMed ID: 14666664 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]